Quantifying the cell morphology and predicting biological behavior of signet ring cell carcinoma using deep learning.

Journal: Scientific reports
PMID:

Abstract

Signet ring cell carcinoma (SRCC) is a malignant tumor of the digestive system. This tumor has long been considered to be poorly differentiated and highly invasive because it has a higher rate of metastasis than well-differentiated adenocarcinoma. But some studies in recent years have shown that the prognosis of some SRCC is more favorable than other poorly differentiated adenocarcinomas, which suggests that SRCC has different degrees of biological behavior. Therefore, we need to find a histological stratification that can predict the biological behavior of SRCC. Some studies indicate that the morphological status of cells can be linked to the invasiveness potential of cells, however, the traditional histopathological examination can not objectively define and evaluate them. Recent improvements in biomedical image analysis using deep learning (DL) based neural networks could be exploited to identify and analyze SRCC. In this study, we used DL to identify each cancer cell of SRCC in whole slide images (WSIs) and quantify their morphological characteristics and atypia. Our results show that the biological behavior of SRCC can be predicted by quantifying the morphology of cancer cells by DL. This technique could be used to predict the biological behavior and may change the stratified treatment of SRCC.

Authors

  • Qian Da
    Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Shijie Deng
    Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Jiahui Li
    College of Communication Engineering, Jilin University, Changchun, Jilin China.
  • Hongmei Yi
    Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Xiaodi Huang
    School of Computing and Mathematics, Charles Sturt University, Albury, NSW 2640, Australia.
  • Xiaoqun Yang
    Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Teng Yu
    Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Xuan Wang
    Baylor Scott & White Health, Dallas, TX, USA.
  • Jiangshu Liu
    Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Qi Duan
    Sensetime Research, No. 1900 Hongmei Road, Xuhui District, Shanghai, China.
  • Dimitris Metaxas
  • Chaofu Wang
    Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. wangchaofu@126.com.